Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Non-Current Liabilities (2022 - 2025)

PAVmed (PAVM) has 4 years of Total Non-Current Liabilities data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities changed N/A year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, changed N/A, while the annual FY2024 figure was $1.8 million, 86.09% down from the prior year.
  • Total Non-Current Liabilities reached $1.2 million in Q3 2025 per PAVM's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $57.6 million in Q3 2023 and bottomed at $1.2 million in Q3 2025.
  • Average Total Non-Current Liabilities over 4 years is $15.0 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: skyrocketed 2385.25% in 2023, then tumbled 86.09% in 2024.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $2.2 million in 2022, then skyrocketed by 492.62% to $12.9 million in 2023, then crashed by 86.09% to $1.8 million in 2024, then plummeted by 35.72% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $1.2 million in Q3 2025, $1.4 million in Q2 2025, and $1.6 million in Q1 2025.